Your browser doesn't support javascript.
loading
Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study.
Constantinescu, Andrei-Emil; Bull, Caroline J; Jones, Nicholas; Mitchell, Ruth; Burrows, Kimberley; Dimou, Niki; Bézieau, Stéphane; Brenner, Hermann; Buchanan, Daniel D; D'Amato, Mauro; Jenkins, Mark A; Moreno, Victor; Pai, Rish K; Um, Caroline Y; White, Emily; Murphy, Neil; Gunter, Marc; Timpson, Nicholas J; Huyghe, Jeroen R; Vincent, Emma E.
Afiliación
  • Constantinescu AE; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Bull CJ; Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
  • Jones N; School of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Mitchell R; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Burrows K; Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
  • Dimou N; School of Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Bézieau S; Institute of Life Science, Swansea University Medical School, Swansea, UK.
  • Brenner H; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Buchanan DD; Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
  • D'Amato M; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
  • Jenkins MA; Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
  • Moreno V; Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France.
  • Pai RK; Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France.
  • Um CY; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • White E; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Murphy N; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gunter M; Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.
  • Timpson NJ; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Huyghe JR; Genetic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Vincent EE; Department of Medicine and Surgery, LUM University, Casamassima, Italy.
Int J Cancer ; 154(1): 94-103, 2024 01 01.
Article en En | MEDLINE | ID: mdl-37578112
ABSTRACT
Observational studies have suggested a protective role for eosinophils in colorectal cancer (CRC) development and implicated neutrophils, but the causal relationships remain unclear. Here, we aimed to estimate the causal effect of circulating white blood cell (WBC) counts (N = ~550 000) for basophils, eosinophils, monocytes, lymphocytes and neutrophils on CRC risk (N = 52 775 cases and 45 940 controls) using Mendelian randomisation (MR). For comparison, we also examined this relationship using individual-level data from UK Biobank (4043 incident CRC cases and 332 773 controls) in a longitudinal cohort analysis. The inverse-variance weighted (IVW) MR analysis suggested a protective effect of increased basophil count and eosinophil count on CRC risk [OR per 1-SD increase 0.88, 95% CI 0.78-0.99, P = .04; OR 0.93, 95% CI 0.88-0.98, P = .01]. The protective effect of eosinophils remained [OR per 1-SD increase 0.88, 95% CI 0.80-0.97, P = .01] following adjustments for all other WBC subtypes, to account for genetic correlation between the traits, using multivariable MR. A protective effect of increased lymphocyte count on CRC risk was also found [OR 0.84, 95% CI 0.76-0.93, P = 6.70e-4] following adjustment. Consistent with MR results, a protective effect for eosinophils in the cohort analysis in the fully adjusted model [RR per 1-SD increase 0.96, 95% CI 0.93-0.99, P = .02] and following adjustment for the other WBC subtypes [RR 0.96, 95% CI 0.93-0.99, P = .001] was observed. Our study implicates peripheral blood immune cells, in particular eosinophils and lymphocytes, in CRC development, highlighting a need for mechanistic studies to interrogate these relationships.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Eosinófilos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Eosinófilos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido